NEWMarkets
Avalo Therapeutics (AVTX) CFO Sells $270K in Company Stock
Published on 4/3/2026

AI Summary
Avalo Therapeutics (AVTX) CFO Sullivan sold $270,000 worth of company stock. This transaction may indicate confidence levels from executives regarding the company's future performance. Insider selling can lead to market volatility and may signal potential weaknesses. Understanding these sales is crucial for investors to gauge the sentiment around AVTX.



